Specifications - Bavarian Nordic Smallpox Vaccine Facility, Kvistgård, North Zealand, Denmark

Key Data
Order year	2004
Project type	New vaccine production facility
Location	Kvistgård, North Zealand, Denmark
Estimated investment	DKK250 million (€33.6 million, $41 million)
Completion	Final quarter of 2005
Output chemicals	Third generation smallpox vaccine
Key Players
Sponsor	Bavarian Nordic
Partners	Chiron, Epimmune, Gerolymatos, Impfstoffwerk Dessau-Tornau (IDT) and Vaccine Solutions of Australia
Lead engineer / designer	Novo Nordisk Engineering
Financing	Bavarian Nordic